Psychedelics

US Patent and Trademark Office Publishes BetterLife’s Patent for BETR-001 and Other LSD Derivatives

This published U.S. patent is part of a developing international patent portfolio which cover new 2-bromo-LSD and other LSD derivatives.

Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million

. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...

Mindset Pharma develops an intranasal platform for psychedelic medicines

Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.

Core One Labs moves forward with its clinical development for its psychedelic formulations

These studies will further enhance the Company’s knowledge supporting the use of psychedelics as strong candidates in the treatment ...

MYND Life Sciences files patent applications for psilocybin-based drugs for depression

Mynd's process utilizes specific psilocybin analogues that have the ability to positively impact patients with neuropsychiatric disorders.

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive...